103 related articles for article (PubMed ID: 31862788)
1. Association of Urine Haptoglobin With Risk of All-Cause and Cause-Specific Mortality in Individuals With Type 2 Diabetes: A Transethnic Collaborative Work.
Liu JJ; Liu S; Saulnier PJ; Gand E; Choo RWM; Gurung RL; Hadjadj S; Lim SC;
Diabetes Care; 2020 Mar; 43(3):625-633. PubMed ID: 31862788
[TBL] [Abstract][Full Text] [Related]
2. Urinary Haptoglobin Predicts Rapid Renal Function Decline in Asians With Type 2 Diabetes and Early Kidney Disease.
Liu JJ; Liu S; Wong MD; Gurung RL; Lim SC
J Clin Endocrinol Metab; 2016 Oct; 101(10):3794-3802. PubMed ID: 27459536
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and All-Cause Mortality Risk Associated With Urinary Excretion of 8-oxoGuo, a Biomarker for RNA Oxidation, in Patients With Type 2 Diabetes: A Prospective Cohort Study.
Kjær LK; Cejvanovic V; Henriksen T; Petersen KM; Hansen T; Pedersen O; Christensen CK; Torp-Pedersen C; Gerds TA; Brandslund I; Mandrup-Poulsen T; Poulsen HE
Diabetes Care; 2017 Dec; 40(12):1771-1778. PubMed ID: 29061564
[TBL] [Abstract][Full Text] [Related]
4. Association between serum 25(OH)D
Samefors M; Scragg R; Länne T; Nyström FH; Östgren CJ
Diabet Med; 2017 Mar; 34(3):372-379. PubMed ID: 27862247
[TBL] [Abstract][Full Text] [Related]
5. Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort.
Saulnier PJ; Gand E; Ragot S; Ducrocq G; Halimi JM; Hulin-Delmotte C; Llaty P; Montaigne D; Rigalleau V; Roussel R; Velho G; Sosner P; Zaoui P; Hadjadj S;
Diabetes Care; 2014 May; 37(5):1425-31. PubMed ID: 24623026
[TBL] [Abstract][Full Text] [Related]
6. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
Salinero-Fort MÁ; San Andrés-Rebollo FJ; de Burgos-Lunar C; Abánades-Herranz JC; Carrillo-de-Santa-Pau E; Chico-Moraleja RM; Jiménez-García R; López-de-Andrés A; Gómez-Campelo P;
J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
[TBL] [Abstract][Full Text] [Related]
8. Body Weight Variability and the Risk of Cardiovascular Outcomes and Mortality in Patients With Type 2 Diabetes: A Nationwide Cohort Study.
Nam GE; Kim W; Han K; Lee CW; Kwon Y; Han B; Park S; Park JH; Kim YH; Kim DH; Kim SM; Choi YS; Cho KH; Park YG
Diabetes Care; 2020 Sep; 43(9):2234-2241. PubMed ID: 32641375
[TBL] [Abstract][Full Text] [Related]
9. Orosomucoid in urine predicts cardiovascular and over-all mortality in patients with Type II diabetes.
Christiansen MS; Hommel E; Magid E; Feldt-Rasmussen B
Diabetologia; 2002 Jan; 45(1):115-20. PubMed ID: 11845230
[TBL] [Abstract][Full Text] [Related]
10. Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes.
Cheng YJ; Lauer MS; Earnest CP; Church TS; Kampert JB; Gibbons LW; Blair SN
Diabetes Care; 2003 Jul; 26(7):2052-7. PubMed ID: 12832312
[TBL] [Abstract][Full Text] [Related]
11. The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.
Costacou T; Orchard TJ
J Diabetes Complications; 2016 Mar; 30(2):221-6. PubMed ID: 26684170
[TBL] [Abstract][Full Text] [Related]
12. Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with type 2 diabetes at 10 years of follow-up.
Svendstrup M; Christiansen MS; Magid E; Hommel E; Feldt-Rasmussen B
J Diabetes Complications; 2013; 27(6):570-5. PubMed ID: 23932410
[TBL] [Abstract][Full Text] [Related]
13. Association of haptoglobin phenotype with incident acute myocardial infarction in Chinese patients with type 2 diabetes.
Gurung RL; Yiamunaa M; Liu S; Liu JJ; Chan C; Choo RWM; Ang K; Sum CF; Tavintharan S; Lim SC
Cardiovasc Diabetol; 2019 May; 18(1):65. PubMed ID: 31146758
[TBL] [Abstract][Full Text] [Related]
14. Gamma-glutamyl transferase and the risk of all-cause and disease-specific mortality in patients with diabetes: A nationwide cohort study.
Chung GE; Jeong SM; Yu SJ; Yoo JJ; Cho Y; Lee KN; Shin DW; Kim YJ; Yoon JH; Han K; Cho EJ
J Diabetes; 2024 May; 16(5):e13551. PubMed ID: 38664890
[TBL] [Abstract][Full Text] [Related]
15. Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with type 2 diabetes at five years of follow-up.
Christiansen MS; Hommel E; Magid E; Feldt-Rasmussen B
Diabetologia; 2005 Feb; 48(2):386-93. PubMed ID: 15645208
[TBL] [Abstract][Full Text] [Related]
16. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
[TBL] [Abstract][Full Text] [Related]
17. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study.
Yu D; Shang J; Cai Y; Wang Z; Zhang X; Zhao B; Zhao Z; Simmons D
BMJ Open Diabetes Res Care; 2019; 7(1):e000735. PubMed ID: 31798896
[TBL] [Abstract][Full Text] [Related]
18. Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.
von Scholten BJ; Reinhard H; Hansen TW; Oellgaard J; Parving HH; Jacobsen PK; Rossing P
Diabetologia; 2016 Jul; 59(7):1549-1557. PubMed ID: 27033561
[TBL] [Abstract][Full Text] [Related]
19. Urine Proteome Specific for Eye Damage Can Predict Kidney Damage in Patients With Type 2 Diabetes: A Case-Control and a 5.3-Year Prospective Cohort Study.
Yang JK; Wang YY; Liu C; Shi TT; Lu J; Cao X; Yang FY; Feng JP; Chen C; Ji LN; Xu A
Diabetes Care; 2017 Feb; 40(2):253-260. PubMed ID: 27903615
[TBL] [Abstract][Full Text] [Related]
20. Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.
Costacou T; Ferrell RE; Orchard TJ
Diabetes; 2008 Jun; 57(6):1702-6. PubMed ID: 18332093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
